Determination of the haemoglobin (Hb) concentration and HbA2 range in a population offers a critical screening tool for thalassaemia.6, 7 However, there are very few reports on the clinical reference intervals for β-thalassaemia patients in China. This evidence concerns the gene GSTM1 and thalassemia.